These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6318490)

  • 1. Characteristics of auto-antibodies to bovine TSH in the serum of two patients with Graves' disease.
    Kajita Y; Nakajima Y; Ishida M; Ochi Y; Miyazaki T; Hachiya T; Ijichi H
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):423-30. PubMed ID: 6318490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y; Hamazu M; Kajita Y; Nagata A
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference with thyrotropin receptor antibody determination by a spuriously occurring anti-bovine TSH antibody.
    Iitaka M; Tanikawa T; Sakatsume Y; Yanagisawa M; Hara Y; Ishii J
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):197-203. PubMed ID: 2874680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies.
    Akamizu T; Mori T; Kasagi K; Kosugi S; Miyamoto M; Nishino K; Sugawa H; Yokota T; Nakamura H; Konishi J
    Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
    Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing.
    Creagh FM; Howells RD; Williams S; Didcote S; Hashim FA; Petersen VB; Rees Smith B
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):79-88. PubMed ID: 3011318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TSH receptor antibodies in Graves' disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors.
    de Bruin TW; van der Heide D
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):330-40. PubMed ID: 6322495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of LATS activity and TSH receptor antibody in Graves' disease.
    Kajita Y; Nakajima Y; Ishida M; Ura Y; Ochi Y; Miyazaki T; Hachiya T; Ijichi H
    Endocrinol Jpn; 1984 Jun; 31(3):369-74. PubMed ID: 6094169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
    Davies TF; Platzer M
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of autoantibody to human thyrotropin (TSH) and autoanti-idiotypic antibody to antihuman TSH antibody in a case with simple goiter.
    Ochi Y; Inui T; Hachiya T; Nakajima Y; Ishida M; Kajita Y; Fujikawa H; Ogura H
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1163-7. PubMed ID: 2121767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TSH antibodies in Graves' disease and their failure to interact with TSH receptor antibodies.
    Ochi Y; Nagamune T; Nakajima Y; Ishida M; Kajita Y; Hachiya T; Ogura H
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):773-7. PubMed ID: 2567103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders.
    Akamizu T; Mori T; Imura H; Noh J; Hamada N; Ito K; Koizumi Y; Yamada T; Fujihira T; Eto S
    J Endocrinol Invest; 1989; 12(7):483-8. PubMed ID: 2571629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSH receptor binding and thyroid stimulation by sera from patients with Graves' disease.
    Ginsberg J; Shewring G; Smith BR
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):305-11. PubMed ID: 6138173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.